Drug Approval | February 21, 2022
Strides receives USFDA approval for Amantadine Hydrochloride capsules
To be marketed by Strides Pharma Inc. in the US market
To be marketed by Strides Pharma Inc. in the US market
In the interim, Deepak Khanna will lead Human Health International.
Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
Resolv ER may remedy leading causes of blindness in adults
Dr. Peter Houghton will lead the research collaboration for GCCRI and is widely regarded as a leading expert in pediatric cancer research and in the development of novel approaches to treating childhood cancers
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing
Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
Adds five years of market exclusivity on approval
Subscribe To Our Newsletter & Stay Updated
